Pittsburgh Business Times Features Biotechnology Program
The Pittsburgh Business Times recently featured the Master of Science in Biotechnology and Management (MSBTM) program, a partnership of the Tepper School of Business, the Mellon College of Science and the Heinz School of Public Policy.
From developing life-saving drugs to cleaning up toxins, biotechnology companies are transforming the way we look at human health and the environment. Now, Carnegie Mellon University is transforming the way we train future managers in the biotech industry. A new breed of successful managers must handle the business of biotechnology and have a solid grasp of the complex science that underlies it. To meet the growing need for managers with such breadth and depth of expertise, Carnegie Mellon is launching the first Master of Science degree in Biotechnology and Management (MSBTM).
Unlike other universities, which host their biotechnology programs and degrees in schools of engineering or science, the MSBTM is the only truly interdisciplinary program that ensures an equally balanced yet in-depth emphasis on business and science. The goal of the new program, is to train managers who can to fill a new niche within the biotech industry. This new generation of managers must simultaneously balance regulatory, scientific and business issues as they communicate between and advise the company's chief executive officer and chief scientist.
